Alternative Measures of Hyperglycemia and Risk of Alzheimer’s Disease in the Community: The Hisayama Study | Zendy

Naoko Mukai | Zendy; Tomoyuki Ohara | Zendy; Jun Hata | Zendy; Yoichiro Hirakawa | Zendy; Daigo Yoshida | Zendy; Hiro Kishimoto | Zendy; Masafumi Koga | Zendy; Udai Nakamura | Zendy; Takanari Kitazono | Zendy; Yutaka Kiyohara | Zendy; Toshiharu Ninomiya | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Alternative Measures of Hyperglycemia and Risk of Alzheimer’s Disease in the Community: The Hisayama Study

Author(s) -

Naoko Mukai,

Tomoyuki Ohara,

Jun Hata,

Yoichiro Hirakawa,

Daigo Yoshida,

Hiro Kishimoto,

Masafumi Koga,

Udai Nakamura,

Takanari Kitazono,

Yutaka Kiyohara,

Toshiharu Ninomiya

Publication year - 2017

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2017-00439

Subject(s) - quartile , hazard ratio , medicine , confidence interval , glycated hemoglobin , confounding , incidence (geometry) , gastroenterology , diabetes mellitus , dementia , disease , type 2 diabetes , endocrinology , physics , optics

We investigated the associations of hemoglobin A1c (HbA1c), glycated albumin (GA), GA/HbA1c ratio, and 1,5-anhydroglucitol (1,5-AG) with the development of Alzheimer's disease (AD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research